NPI: 1073576153 · CUDAHY, CA 90201 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/10/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/10/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 18,749 | $4.11M |
| 2019 | 15,661 | $1.64M |
| 2020 | 22,953 | $3.02M |
| 2021 | 28,205 | $2.88M |
| 2022 | 20,634 | $3.12M |
| 2023 | 22,342 | $3.73M |
| 2024 | 19,790 | $2.87M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 74,769 | 7,650 | $16.11M |
| 0821 | 4,934 | 1,298 | $4.76M | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 22,760 | 3,128 | $225K |
| J1270 | Injection, doxercalciferol, 1 mcg | 11,658 | 1,597 | $106K |
| J1756 | Injection, iron sucrose, 1 mg | 10,089 | 3,436 | $54K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,215 | 727 | $46K |
| A4657 | Syringe, with or without needle, each | 11,553 | 2,827 | $43K |
| 0250 | 4,311 | 273 | $10K | |
| 83970 | 1,374 | 1,334 | $5K | |
| 90674 | 191 | 188 | $3K | |
| 90747 | 51 | 49 | $3K | |
| 82108 | 245 | 232 | $2K | |
| 90662 | 77 | 77 | $2K | |
| 82728 | 742 | 708 | $1K | |
| 85048 | 1,324 | 1,269 | $1K | |
| 83550 | 681 | 649 | $753.91 | |
| G0008 | Administration of influenza virus vaccine | 84 | 83 | $628.47 |
| 83540 | 792 | 758 | $562.24 | |
| 87340 | 18 | 16 | $483.91 | |
| 85041 | 1,332 | 1,282 | $324.22 | |
| 90661 | 13 | 13 | $131.15 | |
| 0302 | 73 | 60 | $28.28 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 48 | 32 | $1.67 |